Payments for dermatologicals continue to rise while payments for opioids continue to fall, according to a report released Thursday by the Workers Compensation Research Institute.
WCRI said that the increase in payments for such drugs that are applied to the skin, usually for pain, is driven by the delivery of more expensive products from doctor’s surgeries and mail order pharmacies.
The report examined government trends in payments for prescription drugs within worker compensation for non-COVID-19 claims from the first quarter of 2018 to the first quarter of 2021.
WCRI reports significant intergovernmental variations in payments per claim for dermatologicals ranging from $ 10 per claim in Minnesota to $ 312 per claim in Pennsylvania. Payment rates for this drug group increased by at least 10 percentage points in seven states.
“Physician dispensing of dermatologicals contributed to the rapid growth in Connecticut, Florida, Georgia and Michigan; and increases in more expensive drugs delivered from certain pharmacies were seen in Louisiana, Pennsylvania and South Carolina,” WCRI said.
The quarterly claims per claim for non-steroidal anti-inflammatory drugs varied widely between states during the first quarter, from $ 21 per claim in Massachusetts and Minnesota to $ 129 per claim in Florida. California saw a large increase in pay-per-view and pay-per-view claims for NSAIDs, driven by a relatively small number of prescriptions for certain drugs at a much higher price, WCRI said.
WCRI said that there is still a large variation in payments per claim for opioids despite the continued reduction in opioid dispensing. Payments per opioid claim in the first quarter were $ 54 in Louisiana, almost twice as high as the second highest state and more than three times the median value of 28 states. In the lower end, the opioid claim was $ 3 in California, according to WCRI.
WorkCompCentral is a sister magazine to Business Insurance. More stories here.